Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720695 | PMC |
| http://dx.doi.org/10.1016/j.japh.2020.11.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A qualitative study to investigate pharmacovigilance systems in Dubai hospitals.
PLoS One
September 2025
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia.
Background: Ensuring the safety of medications is a significant public health priority, with developed countries implementing robust pharmacovigilance programs. Despite this, healthcare providers continue to underreport adverse drug reactions (ADRs). This study aims to explore the existing pharmacovigilance system and procedure followed for ADR reporting in selected Dubai hospitals.
View Article and Find Full Text PDFInsights Into Pharmacist-Led Deprescribing of Benzodiazepines and Related Drugs: A Qualitative Study With Physicians and Pharmacists.
Basic Clin Pharmacol Toxicol
October 2025
HUS Pharmacy, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist-led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's primary care health centres. To explore pharmacists' and physicians' insights, qualitative semi-structured interviews were conducted via Microsoft Teams with physicians and pharmacists involved in a pharmacist-led deprescribing.
View Article and Find Full Text PDFHypertension care: the knowledge and attitudes of the community pharmacists.
J Pharm Policy Pract
September 2025
Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.
Background: Hypertension is a major global risk factor for cardiovascular disease and mortality. In Greece, prevalence is about 40%, with many cases undiagnosed or poorly managed. While doctors remain central to diagnosis and treatment, community pharmacists, as accessible healthcare professionals, can support early detection and ongoing management.
View Article and Find Full Text PDFAntibiotic awareness: exploring knowledge among culturally and linguistically diverse patients.
Antimicrob Steward Healthc Epidemiol
August 2025
Pharmacy Department, Blacktown Hospital, Blacktown, NSW, Australia.
Background: Effective antimicrobial stewardship (AMS) programs must address the needs of culturally and linguistically diverse (CALD) patients who often experience language barriers and varying cultural beliefs regarding antibiotics. They are at greater risk of receiving suboptimal or inappropriate care, yet guidance to support AMS practices for this population remains limited.
Aim: To investigate antibiotic knowledge, perspectives, and experiences of CALD patients.